Soltani, N., Robinson, D. E, Miller, R. T. and Sikkema, P. H. 2015. Length of residual activity of saflufenacil/dimethenamid-p in soybean (Glycine max). Can. J. Plant Sci. 95: 727-733. A total of six field studies were conducted over a 2-yr period (2009, 2010) at three Ontario locations to determine the length of residual activity of saflufenacil/dimethenamid-p applied preemergence (PRE) for the control of annual weeds in soybean. As the rate of saflufenacil/dimethenamid-p increased from 0 to 980 g a.i. ha-1 the maximum cumulative emergence percentage for common lambsquarters, redroot pigweed and common ragweed decreased. Additionally, as the saflufenacil/dimethenamid-p rate increased from 0 to 980 g a.i. ha-1, the cumulative emergence of common lambsquarters, redroot pigweed and common ragweed slowed down over time. Times to 10% emergence were 1.0, 1.0, 2.1, 3.2, 3.9, 6.6 and >12 wk for common lambsquarters, 1.4, 1.6, 1.8, 2.6, 4.3, >12 and >12 wk for redroot pigweed and 0.8, 1.0, 2.2, 2.7, 3, >12 and >12 wk for common ragweed with saflufenacil/dimethenamid-p applied at 0, 30.625, 61.25, 122.5, 245, 490 and 980 g a.i. ha-1, respectively. Based on these results, saflufenacil/dimethenamid-p applied PRE at the labelled use rate of 245 g a.i. ha-1 can provide as much as 3.9, 4.3 and 3wk of effective control of common lambsquarters, redroot pigweed and common ragweed, respectively in soybean.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 95 • No. 4